Results 171 to 180 of about 4,626,170 (385)

Docetaxel as neoadjuvant therapy for radically treatablestage III non-small-cell lung cancer: a multinational randomised phase III study [PDF]

, 2002
K. Mattson, Raymond P. Abratt, G. ten Velde, K Krofta   +3 more
openalex   +1 more source

Neoadjuvant endocrine therapy

The Breast, 2021
openaire   +3 more sources

DLL4-targeted CAR-T therapy sensitizes neoadjuvant chemotherapy via eliminating cancer stem cells and reshaping immune microenvironment in HER2+ breast cancer

Journal for ImmunoTherapy of Cancer
Background Neoadjuvant therapy with trastuzumab, pertuzumab and paclitaxel (THP) has significantly improved the prognosis of patients with human epidermal growth factor receptor 2 (HER2)+ breast cancer (BC).
Tianxing Zhou, Yongjie Xie, Yanfang Yang, Ziyun Liu, Jingrui Yan   +4 more
doaj   +1 more source

Neoadjuvant therapy of rectal carcinoma with UFT–leucovorin plus radiotherapy [PDF]

, 2002
Jaime Feliú, Jorge Calvillo‐Arbizu, A. Escribano, Javier de Castro, Maria E. Sanchez, Alberto G. Mata, Enrique Espinosa, Antonio García Grande, A. Mateo, Manuel González Barón   +9 more
openalex   +1 more source

Neoadjuvant Therapy in Breast Cancer

, 2012
This is an exciting time we live in. As technology has advanced at lightning speed, so has molecular science and knowledge. With the mapping of the genome, a transformation in medical science has followed. Translational application of bench research to the bedside has blossomed also at an unprecedented pace.
Angela Lewis Traylor, Nathalie Johnson, Esther Han   +2 more
openaire   +4 more sources

Combating cancer immunotherapy resistance: a nano‐medicine perspective

Cancer Communications, EarlyView.
Abstract Cancer immunotherapy offers renewed hope for treating this disease. However, cancer cells possess inherent mechanisms that enable them to circumvent each stage of the immune cycle, thereby evading anti‐cancer immunity and leading to resistance.
Xiangyi Kong, Xintong Xie, Juan Wu, Xiangyu Wang, Wenxiang Zhang, Shuowen Wang, Daria Valerievna Abbasova, Yi Fang, Hongnan Jiang, Jidong Gao, Jing Wang   +10 more
wiley   +1 more source

Neoadjuvant therapy: A novel and effective treatment for stage IIIb non-small cell lung cancer

, 1994
John J. Crowley, Valerie W. Rusch, Kathy S. Albain, Thomas W. Rice, Vassyl A. Lonchyna, Robert J. McKenna, K. Stelzer, Robert B. Livingston   +7 more
openalex   +1 more source

Targeting MAN1B1 potently enhances bladder cancer antitumor immunity via deglycosylation of CD47

Cancer Communications, EarlyView.
Abstract Background Only a few bladder cancer patients benefit from anti‐programmed cell death protein 1/programmed cell death ligand 1 immunotherapy. The cluster of differentiation 47 (CD47) plays an important role in tumor immune evasion. CD47 is a highly glycosylated protein, however, the mechanisms governing CD47 glycosylation and its potential ...
Jie Zhang, Chen Zhang, Ruichen Zang, Weiwu Chen, Yining Guo, Haofei Jiang, Jing Le, Kunyu Wang, Haobo Fan, Xudong Wang, Sisi Mo, Peng Gao, Wenhao Guo, Xinrong Jiang, Fengbin Gao, Junming Jiang, Juyan Zheng, Yuxing Chen, Yicheng Chen, Yanlan Yu, Guoqing Ding   +20 more
wiley   +1 more source

Evaluating neoadjuvant therapy effectiveness on systemic disease: use of a prostatic-specific membrane reverse transcription polymerase chain reaction

, 1998

openalex   +1 more source

Neoadjuvant or adjuvant therapy for resectable esophageal cancer: a systematic review and meta-analysis [PDF]

, 2004
Richard Malthaner, Rebecca Wong, R. Bryan Rumble, Lisa Zuraw   +3 more
openalex   +1 more source